Teirlinck, Anne

Dr. Anne Teirlinck is an Epidemiologist specializing in respiratory infections at the RIVM - Centre for Infectious Disease Control in the Netherlands. Her research focuses on respiratory syncytial virus (RSV), COVID-19, and influenza, contributing to national and international surveillance efforts to track and mitigate the spread of infectious diseases.

Dr. Teirlinck has been actively involved in RSV surveillance and vaccine effectiveness studies, collaborating with experts across Europe to improve prevention strategies. She has co-authored research on the burden of RSV-associated hospitalizations in children under five years of age, providing valuable insights into the impact of the virus on pediatric populations. Her work has helped shape recommendations for RSV surveillance at the national level, ensuring that healthcare systems can respond effectively to outbreaks.

Her contributions extend to COVID-19 epidemiology, where she has examined sex differences in COVID-19 mortality in the Netherlands and the broader implications of pandemic-related health disparities. She has also participated in studies analyzing the effectiveness of vaccines and monoclonal antibodies against RSV, supporting the development of immunization strategies.

Beyond her research, Dr. Teirlinck plays a key role in public health policy and infectious disease monitoring, working with national health authorities to refine surveillance methodologies. She has contributed to annual reports on respiratory infections, assessing trends in influenza, pneumonia, and other respiratory diseases to inform public health interventions.

‍